Managing congenital hyperinsulinism: improving outcomes with a multidisciplinary approach

References

• Bruining GJ. Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus. Curr Opin Pediatr. 1990;2(4):758–765.
   Google Scholar
• Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest. 2007;117(4):868–870.
   PubMed Web of Science ®Google Scholar
• Lord K, Dzata E, Snider KE, Gallagher PR, De Leon DD. Clinical presentation and management of children with diffuse and focal hyperinsulinism: a review of 223 cases. J Clin Endocrinol Metab. 2013;98(11):E1786–E1789.
   Web of Science ®Google Scholar
• De León DD, Stanley CA. Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia. Best Pract Res Clin Endocrinol Metab. 2013;27(6):763–769.
   PubMed Web of Science ®Google Scholar
• Levitt Katz LE, Satin-Smith MS, Collett-Solberg P, et al. Insulin-like growth factor binding protein-1 levels in the diagnosis of hypoglycemia caused by hyperinsulinism. J Pediatr. 1997;131(2):193–199.
   Web of Science ®Google Scholar
• Stanley CA, Baker L. Hyperinsulinism in infancy: diagnosis by demonstration of abnormal response to fasting hypoglycemia. Pediatrics. 1976;57(5):702–711.
   Web of Science ®Google Scholar
• Finegold DN, Stanley CA, Baker L. Glycemic response to glucagon during fasting hypoglycemia: an aid in the diagnosis of hyperinsulinism. J Pediatr. 1980;96(2):257–259.
   Web of Science ®Google Scholar
• Kelly A, Tang R, Becker S, Stanley CA. Poor specificity of low growth hormone and cortisol levels during fasting hypoglycemia for the diagnoses of growth hormone deficiency and adrenal insufficiency. Pediatrics. 2008;122(3):e522–e528.
   Web of Science ®Google Scholar
• Tin W. Defining neonatal hypoglycaemia: a continuing debate. Semin Fetal Neonatal Med. 2014;19(1):27–32.
   PubMed Web of Science ®Google Scholar
• Adamkin DH. Newborn CoFa. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011;127(3):575–579.
   PubMed Web of Science ®Google Scholar
• Cornblath M, Reisner SH. Blood glucose in the neonate and its clinical significance. N Engl J Med. 1965;273(7):378–381.
   Web of Science ®Google Scholar
• Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. Br Med J. 1988;297(6659):1304–1308.
   PubMed Web of Science ®Google Scholar
• Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr. 2012;161(5):787–791.
   PubMed Web of Science ®Google Scholar
• Maayan-Metzger A, Lubin D, Kuint J. Hypoglycemia rates in the first days of life among term infants born to diabetic mothers. Neonatology. 2009;96(2):80–85.
   PubMed Web of Science ®Google Scholar
• Hoe FM, Thornton PS, Wanner LA, Steinkrauss L, Simmons RA, Stanley CA. Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism. J Pediatr. 2006;148(2):207–212.
   Web of Science ®Google Scholar
• Kapoor RR, Locke J, Colclough K, et al. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes. 2008;57(6):1659–1663.
   Web of Science ®Google Scholar
• Stanescu DE, Hughes N, Kaplan B, Stanley CA, De Leon DD. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab. 2012;97(10):E2026–E2030.
   Web of Science ®Google Scholar
• James C, Kapoor RR, Ismail D, Hussain K. The genetic basis of congenital hyperinsulinism. J Med Genet. 2009;46(5):289–299.
   Web of Science ®Google Scholar
• Lord K, De Leon DD. Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management. Int J Pediatr Endocrinol. 2013;2013(1):3.
   Google Scholar
• Palladino AA, Bennett MJ, Stanley CA. Hyperinsulinism in infancy and childhood: when an insulin level is not always enough. Clin Chem. 2008;54(2):256–263.
   Web of Science ®Google Scholar
• Marquard J, Palladino AA, Stanley CA, Mayatepek E, Meissner T. Rare forms of congenital hyperinsulinism. Semin Pediatr Surg. 2011;20(1):38–44.
   Web of Science ®Google Scholar
• Stanley CA, De Leon DD. Monogenic Hyperinsulinemic Hypoglycemia Disorders. 1st ed. Basel, Switzerland: Karger; 2012.
   Google Scholar
• Kapoor RR, Flanagan SE, Arya VB, Shield JP, Ellard S, Hussain K. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol. 2013;168(4):557–564.
   PubMed Web of Science ®Google Scholar
• Snider KE, Becker S, Boyajian L, et al. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab. 2013;98(2):E355–E363.
   Web of Science ®Google Scholar
• Pinney SE, MacMullen C, Becker S, et al. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant K(ATP)channel mutations. J Clin Invest. 2008;118(8):2877–2886.
   Web of Science ®Google Scholar
• Flanagan SE, Xie W, Caswell R, et al. Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation. Am J Hum Genet. 2013;92(1):131–136.
   PubMed Web of Science ®Google Scholar
• Cederblad F, Ewald U, Gustafsson J. Effect of glucagon on glucose production, lipolysis, and gluconeogenesis in familial hyperinsulinism. Horm Res Paediatr. 1998;50(2):94–98.
   Google Scholar
• Miralles RE, Lodha A, Perlman M, Moore AM. Experience with intravenous glucagon infusions as a treatment for resistant neonatal hypoglycemia. Arch Pediatr Adolesc Med. 2002;156(10):999–1004.
   Google Scholar
• Sellers EM, Koch-Weser J. Binding of diazoxide and other benzothiadiazines to human albumin. Biochem Pharmacol. 1974;23(3):553–566.
   Web of Science ®Google Scholar
• Hu S, Xu Z, Yan J, et al. The treatment effect of diazoxide on 44 patients with congenital hyperinsulinism. J Pediatr Endocrinol Metab. 2012;25(11–12):1119–1122.
   Web of Science ®Google Scholar
• Yildizdas D, Erdem S, Kucukosmanoglu O, Yilmaz M, Yuksel B. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy. Adv Ther. 2008;25(5):515–519.
   Web of Science ®Google Scholar
• Reubi JC, Schonbrunn A. Illuminating somatostatin analog action at neuroendocrine tumor receptors. Trends Pharmacol Sci. 2013;34(12):676–688.
   PubMed Web of Science ®Google Scholar
• Laje P, Halaby L, Adzick NS, Stanley CA. Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism. Pediatr Diabetes. 2010;11(2):142–147.
   Web of Science ®Google Scholar
• Harris AG. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut. 1994;35(3 Suppl):S1–S4.
   PubMed Web of Science ®Google Scholar
• Thorton PS, Alter CA. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr. 1993;123(4):637–643.
   Web of Science ®Google Scholar
• Demirbilek H, Shah P, Arya VB, et al. Long-term follow-up of children with congenital hyperinsulinism on octreotide therapy. J Clin Endocrinol Metab. 2014;99(10):3660–3667.
   Web of Science ®Google Scholar
• Yorifuji T, Kawakita R, Hosokawa Y, et al. Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism. Clin Endocinol. 2013;78(6):891–897.
   Web of Science ®Google Scholar
• McCaughan JM. Subtotal pancreatectomy for hyperinsulinism: operative technic. Ann Surg. 1935;101(6):1336–1341.
   Google Scholar
• Ternberg JL. Surgical treatment of idiopathic hyperinsulinemic hypoglycemia in children. First successful subtotal pancreatectomy with preservation of spleen reported by Evarts A. Graham (1934). J Thorac Cardiovasc Surg. 1984;88(5 pt 2):898–901.
   Web of Science ®Google Scholar
• Kassem SA, Ariel I, Thornton PS, et al. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes. 2001;50(12):2763–2769.
   PubMed Web of Science ®Google Scholar
• Sempoux C, Guiot Y, Dahan K, et al. The focal form of persistent hyperinsulinemic hypoglycemia of infancy: morphological and molecular studies show structural and functional differences with insulinoma. Diabetes. 2003;52(3):784–794.
   Web of Science ®Google Scholar
• Rahier J, Guiot Y, Sempoux C. Morphologic analysis of focal and diffuse forms of congenital hyperinsulinism. Semin Pediatr Surg. 2011;20(1):3–12.
   Web of Science ®Google Scholar
• Suchi M, Thornton PS, Adzick NS, et al. Congenital hyperinsulinism: intraoperative biopsy interpretation can direct the extent of pancreatectomy. Am J Surg Pathol. 2004;28(10):1326–1335.
   Web of Science ®Google Scholar
• Suchi M, MacMullen CM, Thornton PS, et al. Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism. Mod Pathol. 2006;19(1):122–129.
   Web of Science ®Google Scholar
• Adzick NS, Thornton PS, Stanley CA, Kaye RD, Ruchelli EA. Multidisciplinary approach to the focal form of congenital hyperinsulinism leads to successful treatment by partial pancreatectomy. J Pediatr Surg. 2004;39(3):270–275.
   Web of Science ®Google Scholar
• Crétolle C, Fékété CN, Jan D, et al. Partial elective pancreatectomy is curative in focal form of permanent hyperinsulinemic hypoglycaemia in infancy: a report of 45 cases from 1983 to 2000. J Pediatr Surg. 2002;37(2):155–158.
   Web of Science ®Google Scholar
• Giurgea I, Sempoux C, Bellanné-Chantelot C, et al. The Knudson’s two-hit model and timing of somatic mutation may account for the phenotypic diversity of focal congenital hyperinsulinism. J Clin Endocrinol Metab. 2006;91(10):4118–4123.
   Web of Science ®Google Scholar
• Beltrand J, Caquard M, Arnoux JB, et al. Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care. 2012;35(2):198–203.
   Web of Science ®Google Scholar
• Lyonnet S, Bonnefont JP, Saudubray JM, Nihoule-Fekete C, Brunelle F. Localisation of focal lesion permitting partial pancreatectomy in infants. Lancet. 1989;334(8664):671.
   Google Scholar
• Stanley CA, Thornton PS, Ganguly A, et al. Preoperative evaluation of infants with focal or diffuse congenital Hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab. 2004;89(1):288–296.
   Web of Science ®Google Scholar
• Laje P, States LJ, Zhuang H, et al. Accuracy of PET/CT scan in the diagnosis of the focal form of congenital hyperinsulinism. J Pediatr Surg. 2013;48(2):388–393.
   Web of Science ®Google Scholar
• Meintjes M, Endozo R, Dickson J, et al. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist’s perspective. Nucl Med Commun. 2013;34(6):601–608.
   Web of Science ®Google Scholar
• Peranteau WH, Bathaii SM, Pawel B, et al. Multiple ectopic lesions of focal islet adenomatosis identified by positron emission tomography scan in an infant with congenital hyperinsulinism. J Pediatr Surg. 2007;42(1):188–192.
   Web of Science ®Google Scholar
• von Rohden L, Mohnike K, Mau H, et al. Visualization of the focus in congenital hyperinsulinism by intraoperative sonography. Semin Pediatr Surg. 2011;20(1):28–31.
   Web of Science ®Google Scholar
• Cherian MP, Abduljabbar MA. Persistent hyperinsulinemic hypoglycemia of infancy (PHHI): long-term outcome following 95% pancreatectomy. J Pediatr Endocrinol Metab. 2005;18(12):1441–1448.
   Web of Science ®Google Scholar
• Lovvorn HN 3rd, Nance ML, Ferry RJ Jr, et al. Congenital hyperinsulinism and the surgeon: lessons learned over 35 years. J Pediatr Surg. 1999;34(5):786–793.
   Web of Science ®Google Scholar
• Mahachoklertwattana P, Suprasongsin C, Teeraratkul S, Preeyasombat C. Persistent hyperinsulinemic hypoglycemia of infancy: long-term outcome following subtotal pancreatectomy. J Pediatr Endocrinol Metab. 2000;13(1):37–44.
   Web of Science ®Google Scholar
• Arya VB, Senniappan S, Demirbilek H, et al. Pancreatic endocrine and exocrine function in children following near-total pancreatectomy for diffuse congenital hyperinsulinism. PLoS One. 2014;9(5):e98054.
   Web of Science ®Google Scholar
• Kalish JM, Jiang C, Bartolomei MS. Epigenetics and imprinting in human disease. Int J Dev Biol. 2014;58(2–4):291–298.
   PubMed Web of Science ®Google Scholar
• Munns C, Batch J. Hyperinsulinism and Beckwith-Wiedemann syndrome. Arch Dis Child Fetal Neonatal Ed. 2001;84(1):F67–F69.
   Web of Science ®Google Scholar
• Laje P, Palladino AA, Bhatti TR, States LJ, Stanley CA, Adzick NS. Pancreatic surgery in infants with Beckwith-Wiedemann syndrome and hyperinsulinism. J Pediatr Surg. 2013;48(12):2511–2516.
   Web of Science ®Google Scholar
• Huang T, Kelly A, Becker SA, Cohen MS, Stanley CA. Hypertrophic cardiomyopathy in neonates with congenital hyperinsulinism. Arch Dis Child Fetal Neonatal Ed. 2013;98(4):F351–F354.
   PubMed Web of Science ®Google Scholar
• Bier DM, Leake RD, Haymond MW, et al. Measurement of “true” glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes. 1977;26(11):1016–1023.
   Web of Science ®Google Scholar
• Al-Zubeidi H, Gottschalk ME, Newfield RS. Successful use of long acting octreotide in two cases with Beckwith-Wiedemann syndrome and severe hypoglycemia. Int J Pediatr Endocrinol. 2014;2014(1):18–18.
   Google Scholar
• Le Quan Sang KH, Arnoux JB, Mamoune A, et al. Successful treatment of congenital hyperinsulinism with long-acting release octreotide. Eur J Endocrinol. 2012;166(2):333–339.
   Web of Science ®Google Scholar
• Dalit M-M, Ilana K, Kineret M-A, Orit P-H, Heddy L. Treatment of congenital hyperinsulinism with lanreotide acetate (somatuline autogel). J Clin Endocrinol Metab. 2011;96(8):2312–2317.
   Web of Science ®Google Scholar
• Mazor-Aronovitch K, Gillis D, Lobel D, et al. Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism. Eur J Endocrinol. 2007;157(4):491–497.
   Web of Science ®Google Scholar
• Mohnike K, Blankenstein O, Pfuetzner A, et al. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon. Horm Res Paediatr. 2008;70(1):59–64.
   Google Scholar
• Fourtner SH, Stanley CA, Kelly A. Protein-sensitive hypoglycemia without leucine sensitivity in hyperinsulinism caused by KATP channel mutations. J Pediatr. 2006;149(1):47–52.
   Web of Science ®Google Scholar
• Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA. Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001;138(3):383–389.
   Web of Science ®Google Scholar
• Glaser B, Hirsch HJ, Landau H. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr. 1993;123(4):644–650.
   Web of Science ®Google Scholar
• Leibowitz G, Glaser B, Higazi AA, Salameh M, Cerasi E, Landau H. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab. 1995;80(2):386–392.
   Web of Science ®Google Scholar
• Grimberg A, Ferry RJ, Kelly A, et al. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations. Diabetes. 2001;50(2):322–328.
   Web of Science ®Google Scholar
• Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes. 2000;49(8):1325–1333.
   Web of Science ®Google Scholar
• Abdulhadi-Atwan M, Bushman J, Tornovsky-Babaey S, et al. Novel de novo mutation in Sulfonylurea Receptor 1 presenting as hyperinsulinism in infancy followed by overt diabetes in early adolescence. Diabetes. 2008;57(7):1935–1940.
   Web of Science ®Google Scholar
• Al-Nassar S, Sakati N, Al-Ashwal A, Bin-Abbas B. Persistent hyperinsulinaemic hypoglycaemia of infancy in 43 children: long-term clinical and surgical follow-up. Asian J Surg. 2006;29(3):207–211.
   Web of Science ®Google Scholar
• Meissner T, Wendel U, Burgard P, Schaetzle S, Mayatepek E. Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur J Endocrinol. 2003;149(1):43–51.
   Web of Science ®Google Scholar
• Rother KI, Matsumoto JM, Rasmussen NH, Schwenk WF. Subtotal pancreatectomy for hypoglycemia due to congenital hyperinsulinism: long-term follow-up of neurodevelopmental and pancreatic function. Pediatr Diabetes. 2001;2(3):115–122.
   Google Scholar